ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

First quarter 2019 revenue of $136 million First quarter 2019 net loss of $8 million First quarter 2019 Adjusted EBITDA1 of $65 million Generated cash flow from operations of $46 million in the...